GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 3.087 11 days ( -86.79 % )
Last Price $0.157 -11.41 %
High/ Low $0.154 - $0.172 53.49%
Chg 7 Days 73.75 % $0.0903 $0.157
Chg 30 Days 96.37 % $0.0799 $0.157
Chg 12 mos -73.23 % $0.586 $0.157
Trend - 3 mos 10.98 % Width: 163.50 %
Trend - 12 mos -67.28 % Width: 361.25 %
Pred. range - 3 mos $0.0755 - $0.199 -51.91 % - 26.72 %
Pred. range - 12 mos N/A - $0.110 -100.00 % - -30.11 %
Short MA avg 3 mos Sell 2024-04-11 - 7 days
Long MA avg 3 mos Buy 2024-04-03 - 13 days
Short/Long MA avg 3 mos Buy 2024-04-04 - 12 days
Short MA avg 12 mos Buy 2024-04-03 - 13 days
Long MA avg 12 mos Buy 2024-04-15 - 5 days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Sell 2024-04-16 - 4 days
Bollinger Buy 2023-07-24 - 188 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT